Research projects receive NHMRC funding

13 Oct 2022

The National Health and Medical Research Council has awarded Investigator Grants to five Faculty of Medicine researchers.

The grants foster innovative and creative research for high performing researchers across all stages of their careers and enable them to establish their own research program.

Congratulations to the following Faculty of Medicine researchers and their teams.

NHMRC Investigator Grants

Antenatal influenza, pertussis and now COVID vaccines reduce the severity of these illnesses and prevent deaths in pregnancy and young babies. We need to know the uptake, safety and effectiveness of these vaccines in pregnancy using large study numbers and gold standard methods.

Babies that grow slowly before birth are more likely to suffer brain damage. There is no way to prevent this brain damage, it is difficult to detect, and there are no treatments. This work will provide new knowledge on not only tests to detect brain damage to identify these babies earlier, but it will also explore treatments to improve life-long outcomes for these children.

Infections commonly occur following kidney transplantation and are associated with significant morbidity and mortality. This research program addresses this public health burden by designing clinical trials that are of critical importance to patients, caregivers and healthcare professionals.

Cardiac rehabilitation (CR) enables people who have suffered a heart event to self-manage their condition and improve their quality of life. However, many eligible patients (70%) do not attend. Telehealth-delivered CR can reduce access barriers, is safe, effective and is well-liked by patients. This project aims to provide a major health system impact by supporting the expanded use of telehealth across CR services.

This research aims to generate new knowledge on common brain disorders by using advanced statistical methods to integrate large-scale genetics and genomics with deep clinical and lifestyle data. Ultimately, this is expected to underpin improved clinical outcomes and quality of life through prevention, earlier diagnosis, and safer evidence-based treatments.

More information about the grants is available from the NHMRC.